Bellevue Life Sciences Acquisition

BLAC

3.0100.00% ( 0.000 )

Suspended: Oct 20, 09:20:00 (EDT)

Q3 FY2024 Earnings

Financial report interval: 2024.06.30 - 2024.09.30

Overview: Bellevue Life Sciences Acquisition(BLAC) the EBIT is -454.13 K (-10.65%);the EPS is -0.06 (-794.9%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

EBIT

-0.00B10.65%

----

----

EPS

-0.06794.92%

----

----

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly